Recruiting
Phase 3

Carboplatin & Paclitaxel & Pembrolizumab

Sponsor:

National Cancer Institute (NCI)

Code:

NCT07061977

Conditions

Locally Advanced Cervical Adenocarcinoma

Locally Advanced Cervical Adenosquamous Carcinoma

Locally Advanced Cervical Squamous Cell Carcinoma

Stage IIIA Cervical Cancer FIGO 2018

Stage IIIB Cervical Cancer FIGO 2018

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Brachytherapy

Carboplatin

Chest Radiography

Cisplatin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-27. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-10-24.